Winners of the 2014 Reaxys PhD Prize Announced

The 5th annual Reaxys PhD Prize awards original and innovative research in organic, organometallic and inorganic chemistry

Amsterdam, July 16, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the winners of the 2014 Reaxys PhD Prize. Awarding innovative and original research in organic, organometallic and inorganic chemistry, the Reaxys PhD Prize celebrates top research conducted by leading young chemists across the globe.

Selected from among 45 finalists representing some of today's brightest young chemists, the 2014 Reaxys PhD Prize Winners, and their representative, peer-reviewed articles are:

This year, more than 500 submissions were received from nearly 400 universities across the globe. Submissions consisted of a representative, peer-reviewed, published research paper accompanied by a CV and PhD supervisor recommendation letter. Entries were reviewed by over 70 international chemists from academia and industry. The reviewers judged the entries for originality, innovation, importance to the field, applicability, rigor of approach and publication quality.

The 2014 Chairs of the Reaxys PhD Prize's review board are: Professors Tony Barrett (Imperial College London, UK), Eiichi Nakamura (University of Tokyo, Japan), Gerard Parkin (Columbia University, New York, USA), Martin Jansen (Max-Planck Institute, Stuttgart, Germany), Barry Trost (Stanford University, USA) and Henry Wong (The Chinese University Hong Kong, Hong Kong).

Running for the 5th year, the Reaxys PhD Prize has become the world's most important prize for Chemistry PhD students. To date, over 2,200 applications have been received from well over 400 universities across the globe.

"The Reaxys PhD Prize received submissions from over 60 countries – it has become the premier international prize showcasing inspiring chemistry," said Dr. David Evans, Scientific Affairs Director at Reed Elsevier Properties SA. "Each year we invite the prize winners and finalists to join the Reaxys Prize Club, promoting networking and collaboration. They will join the 180 similarly minded individuals, finalists and winners from previous years, representing a wide variety of skills and research expertizes – this is an amazing opportunity to connect with peers from both industry and academia, many of whom will undoubtedly play a key role in the future of chemistry."

The winners and all finalists of this year's prize have been invited to attend the Reaxys Inspiring Chemistry Conference which will be held in Grindelwald, Switzerland, September 21 – 24, 2014, where they will be given the opportunity to present their research. Details about the conference are available online at: http://inspiringchemistry.reaxys.com/conference.

For more information about the Reaxys PhD Prize, including the full list of the 45 finalists go to: http://inspiringchemistry.reaxys.com/phdprize 

---

About Reaxys®
Reaxys® is a workflow solution for research chemists. Offering a wealth of experimentally validated information, Reaxys® combines reaction and substance data in organic, organometallic, inorganic and physical chemistry with synthesis planning. Researchers can get the information they need in a single overview, from source publications carefully selected for their importance and relevance to research chemists. Elsevier continues to engage with the chemistry community to ensure that Reaxys® continues to reflect how chemists think and work. For more information please visit Reaxys.

Reaxys and the Reaxys trademark are owned and protected by Reed Elsevier Properties SA and used under license.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Amy Burnis
Director, Strategic Communications
Elsevier
+1 617 803 8344
a.burnis@elsevier.com